Newbridge Financial Services Group, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $262 Million
- Q2 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 12,000 shares of DNA stock, worth $88,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,000
Previous 14,000
14.29%
Holding current value
$88,920
Previous $16,000
81.25%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.06 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.03 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$996 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$518 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$311 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $9.54B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...